| Serial Number | 79365402 |
| Word Mark | DNADX |
| Filing Date | Monday, February 6, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, July 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 2, 2024 |
| Goods and Services | Diagnostic preparations for medical purposes, in the field of cancer; diagnostic reagents for medical use, in the field of cancer; diagnostic biomarker reagents for medical purposes, in the field of cancer; clinical medical reagents, in the field of cancer; medical diagnostic reagents for use in analysis of circulating tumor DNA extracted from blood samples, for use in the field of cancer; medical diagnostic reagents for use in diagnostic tests, in the field of cancer; biomarkers being copy number alterations and gene mutation for the diagnosis, prognosis and treatment of cancer; medical diagnostic reagents and assays for the diagnosis, prognosis and treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; compounds, namely, chemotherapy drugs, inmunotherapy agents, targeted drug therapies and hormonal therapies for treating cancer; pharmaceutical preparations for use in oncology; biological reagents for medical use, in the field of cancer; diagnostic reagent kits comprised of medical diagnostic reagents and assays for testing body fluids for medical use in the field of cancer. |
| Pseudo Mark | DNA DX; DNA DIAGNOSIS |
| Goods and Services | Diagnostic preparations for scientific purposes, in the field of cancer; reagents for research purposes, in the field of cancer; reagents for medical research, in the field of cancer; diagnostic reagents for scientific or research use, in the field of cancer; reagents for scientific or research use in the field of cancer; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, in the field of cancer |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 17, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 17, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | REVEAL GENOMICS S.L. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | ES |
| Party Name | REVEAL GENOMICS S.L. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | ES |
| Event Date | Event Description |
| Thursday, March 16, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 21, 2023 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 3, 2023 | ASSIGNED TO EXAMINER |
| Saturday, November 4, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, November 3, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 7, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, February 12, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 12, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, February 12, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 12, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, February 12, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, February 12, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 7, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, November 28, 2023 | REFUSAL PROCESSED BY IB |
| Tuesday, May 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 11, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, June 11, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 12, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, July 1, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, July 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |